Alemtuzumab for Multiples Sclerosis: Who and When to treat?Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012
Severely Threatening Events and Marked Life Difficulties Preceding Onset or Exacerbation of MSJNNP 52:8-13, Grant,I.,et al, 1989